Loading...

SCYNEXIS, Inc.

SCYX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.02
$-0.03(-2.86%)
U.S. Market opens in NaNh NaNm

SCYNEXIS, Inc. (SCYX) Stock Overview

Explore SCYNEXIS, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap45.6M
P/E Ratio-5.21
EPS (TTM)$-0.17
ROE-0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$0.88
3 Months$0.90
1 Year Target$0.25

SCYX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SCYNEXIS, Inc. (SCYX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.14, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.21 and a market capitalization of 45.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.86%
5-Day Change
-6.42%
1-Month Change
13.33%
3-Month Change
23.98%
6-Month Change
32.47%
Year-to-Date (YTD) Change
61.29%
1-Year Change
-4.67%
3-Year Change
-66.23%
5-Year Change
-86.56%
All-Time (Max) Change
-98.87%

Contact Information

https://www.scynexis.com
201 884 5485
1 Evertrust Plaza, Jersey City, NJ, 07302-6548

Company Facts

28 Employees
IPO DateMay 2, 2014
CountryUS
Actively Trading

Frequently Asked Questions